News & views
A collection of stories about our people, our research, and global health.
Browse all news
5 min read
International Day of the Girl 2026
On International Day of the Girl, we look at how young girls are impacted by the endometriosis innovation gap. Symptoms often start with their first periods, yet diagnostics and treatments are largely designed and tested for adult women. Closing this gap is key to ensuring girls are diagnosed sooner, treated safely and able to stay in school.
10 min read
Safe abortion day 2026
This International Safe Abortion Day, we're looking at a dimension of the abortion conversation that rarely receives attention: R&D. Abortion is a common part of reproductive life worldwide, yet R&D funding for it has fallen sharply and rests almost entirely on a single funder. Our latest analysis unpacks the gaps in the product pipeline and what "solidarity in action" should mean for abortion R&D.
5 min read
What the NIH cuts mean for global health - an update
An update on the impact on global health R&D of the cuts to the NIH and underlying changes to the grantmaking process.
10 min read
A choice for all? What seven years of contraceptive, MPT and abortion R&D funding says about agency, intention and access
We analyse seven years of contraceptive, MPT and abortion R&D funding to understand what it tells us about agency, intention and access.
5 min read
Assessing funding for biosafety and biosecurity
We're working with CEPI to examine how biosafety and biosecurity are funded in global health R&D. We invite partners to fill in this short survey to provide us with their views and experience.
2 min read
The Ripple Effect 3.0
The third iteration of Impact Global Health's 'ripple effect' research provides five new case studies to deepen the evidence base for the domestic benefits of global health R&D.
5 min read
No data, no direction
Lis Oversteegen reveals how the G-FINDER survey turns funding data into the insights that drive smarter global health investment.
5 min read
How ‘boom and bust’ Ebola R&D funding leaves us vulnerable
We conducted a deep dive to better understand why there remains such a limited set of tools for the current Bundibugyo strain outbreak in the DRC.
5 min read
UK backs one in five malaria tools in development - as campaigners warn “malaria science superpower” status must be maintained
New research shows UK institutions are involved in R&D for 20% of malaria tools currently in the pipeline – the third highest of any country